Echilibru Hormonal Diindolylmethane

Diindolylmethane pentru promovarea echilibrului hormonal

1 Diindolylmethane pentru promovarea echilibrului hormonal, la sindromul premenstrual si preventia de cancer.

2 Diindolylmethane fitofarmaceutic pentru preventia de cancer si promovarea sanatatii de Dr. Michael A. Zeligs.

3 Diindolylmethane cu actiune anti proliferativa.

Echilibru Hormonal cu Diindolylmethane

Totul despre Diindolylmethane, metabolismul estrogenului, promovarea reducerii greutatii corporale, echilibru hormonal

Tratamente naturiste pentru cancer

Totul despre Diindolylmethane de Dr. Michael A. Zeligs

Diindolylmethane pentru promovarea echilibrului hormonal, sindromul premenstrual si preventia de cancer

Diindolylmethane cu echilibru homonal, anti-cancer, citostatic, anti-angiogeneza, apoptoza, antiinflamator, anti-bacterial, anti-viral, anti-androgen

Biodisponibilitatea la Bioresponse DIM de 2,5 x mai mult DIM Diindolylmethane fata de DIM Diindolylmethane normal (Generic)

1. Indole-3-Carbinol cu efect in metabolismul estrogenului prin cresterea de estrogen 2-hidroxilat, inactiveaza estrogenii endogeni nefavorabili (17beta-estradiol) si estron, reduce riscul de cancer mamar

2. Estrogen, Estrogen plus progestin cu risc de cancer mamar

3. Risc de cancer endometrial in relatia de folosinta de estrogeni combinat cu progestagen la femei in postmenopauza

4. Raspuns de cancer endometrial prin folosinta de estrogeni combinat cu progestagen - Anticonceptionalul - Contraceptivele

5. Celulele tumorale circulatoare (CTC) prezice supravietuire la pacientii cu cancer de prostata metastazat.

Circulatia sangvina a celulelor canceroase

6. Celulele tumorale circulatoare (CTC) versus imaginile obtinute in urma mamografiei prezice supravietuire la cancerul mamar metastazat.

In testul sagvin pentru cancer se masoara numarul de celule tumorale circulatoare (CTC) (the number of circulatory tumor cells (CTC) in the bloodstream)

Test sangvin pentru cancer

Liber de dureri insuportabile: Terapia de substitutie hormonala cu efectele adverse cancer mamar, ovarian, aratat in studiu la un milion de femei

7. Cancer ovarian cauzat prin terapia de substitutie hormonala, studiu la un milion de femei

Ce nu va relateaza medicul despre terapia de substitutie hormonala

Cum echilibrul hormonal poate ajuta salvarea vietii: Dr. John R Lee

8. Terapia de substitutie hormonala cu risc de boli cardiovasculare la femei in menopauza

Echilibru hormonal cu produse-naturale in menopauza Dr. John R Lee

Ce nu va relateaza medicul despre menopauza: Dr. John R Lee

Echilibru Hormonal cu Diindolylmethane in cura cu suplimente nutritive produse-naturale din medicina traditionala

9. Indole-3-Carbinol induce potent citocrome P450 continut masurat la enzimele microsomale hepatice, P450 este dependent in metabolismul de estrogen.

10. Indole-3-Carbinol in tratamentul acut si cronic la cancerului mamar indus de glanda mamara prin oxidarea de (17 beta-estradiol) si estron - Estrogeni nefavorabili, estradiolul poate fi metabolizat in 2 hidroxi estrogen (2OHE) si 2 metoxi estrogen sint estrogeni favorabili, iar estron in: 2 hidroxiestron (2OHE1) si 2 metoxiestron (2MeOE1) estrogeni favorabili

- Estrogen 2 hidroxilaza convertesc estrogenul 2 hidroxi estrogen (2OHE) si 2 metoxi estrogen care sint estrogeni favorabili cu protectie, anti proliferativa

11. Hidrolizarea de 17 beta-estradiol prin catalizarea de citocrome 450 1B1

12. Receptorul AH se leaga de Indole-3-Carbinol si Diindolylmethane care induce hidroxilarea estradiolului, in procesul de hidroxilare estrogen 2 hidroxilaza (EH), microzomala (citocrom P450) este involvat si receptorul AH

Diindolylmethane induce hidroxilarea estradiolului

13 Indole-3-Carbinol si Diindolylmethane este un aril hidrocarbon receptor agonist (AH)

14 Diindolylmethane este un aril hidrocarbon receptor care mediaza ca anti-estrogen si anti cancer

15 Diindolylmethane activeaza receptorul estrogenic (ER) la cancerul mamar

- 2 hidroxiestron (2OHE1) si 2 metoxiestron (2MeOE1) estrogeni favorabili cu protectie pentru organism, anticarcinogenici

- Schimbarea nivelului de metabolitii de estrogen dupa tratamentul cu de Indole-3-Carbinol

16. Estrogeni favorabili: 2 hidroxi estrogen (2OHE) si 2 metoxi estrogen sint estrogeni favorabili cu protectie anti proliferativa

17. 2 Metoxi estrogen un endogen estrogen metabolit care inhiba carcinogeneza mamara

18 Presenta de Diindolylmethane dupa administrarea de Indole-3-Carbinol

- Glucosinolat este catalizat de enzima mirozinaza prin hidroliza de conversie a glucobrassicinei din mediul acid al stomacului in Indole-3-Carbinol.

- Indole-3-Carbinol este un precursor de Diindolylmethane prin: Reactia de condensare DIM Diindolylmethane

19. Hidrolizarea de Glucosinolat in izotiocianati dupa ingestia de Varza cruda

Hidrolizarea de Glucosinolat in izotiocianati dupa ingestia de Varza cruda

20 Diindolylmethane cu efect citostatic la cancerul endometrial rezultat prin medierea receptorului de estrogen

21 Farmacocinetica la Diindolylmethane dupa administrarea de Indole-3-carbinol

22 Diindolylmethane cu influenta la cresterea cancerului mamar si metastaza

23 Diindolylmethane induce apoptoza pe linia celulara MDA MB 231 la cancerul mamar

24 Diindolylmethane are efect supresiv la cancerului mamar cu linia celulara MCF-7

25 Obezitatea, dieta, metabolismul de estrogen afectat: Dominanta estrogenica cu riscul de cancer hormonal

Indicat: Dieta anti-estrogenica, cura de slabire cu Indole-3-Carbinol, Resveratrol sau Diindolylmethane

26 Diindolylmethane si Indole-3-Carbinol cu efect anti estrogenic, un citostatic natural

27. Broccoli inhiba carcinogeneza la vezica urinara

28 Diindolylmethane si Indole-3-Carbinol induce apoptoza la cancerul cervical

Diindolylmethane si Indole-3-Carbinol induce apoptoza la cancerul cervical numit si cancerul de col uterin

29. Germaniu Organic, Alil sulfid din Garlic si I-3-C (Indole-3-carbinol) sau Diindolylmethane inhiba carcinogeneza.

30. Indole-3-Carbinol si Diindolylmethane induce apoptoza la cancerul de prostata

31. Indole-3-Carbinol, Diindolylmethane si sulforafan cu efect la cancerul de prostata: dihidrotestosteronul (DHT) blocker

Indole-3-Carbinol, si Diindolylmethane si sulforafan cu efect la cancerul de prostata: dihidrotestosteronul (DHT) blocker

32. Diindolylmethane la adenomul de prostata (hiperplazia benigna de prostata) si cancer

33. Nivelul de dihidrotestosteronul (DHT) 5a-dihidrotestosteron 5 5a-DHT are efect asupra virstei, testosteronul, estradiolul si estron in stroma celulara a prostatei si hiperplazia celulelor stromale si epiteliale la adenomul de prostata (hiperplazia benigna de prostata)

34. Plante pentru tulburarile de urinare la adenomul de prostata (hiperplazia benigna de prostata): Saw Pallmetto, Pygeum Africanum si Urzica (Nettle) = Prostata Formula

Metabolismul hormonal masculin: Restabilirea echilibrului hormonal

35. Rolul de estrogeni si globulina - sex hormone-binding globulin (SHBG) in fiziologia prostatei

36. Estradiolul activeaza receptorul androgen al prostatei si secretia specifica a prostatei prin globulina - sex hormone-binding globulin (SHBG)

37. Obezitatea, dieta, metabolismul de estrogen afectat: Dominanta estrogenica cu riscul de cancer hormonal

Dominanta estrogenica

Dieta anti-estrogenica indicat la cura de slabire, suplimente nutritive cu specific anti-estrogenic: Indole-3-Carbinol, Resveratrol, Diindolylmethane, Isoflavone si Prostata Formula

Dieta anti-estrogenica, dieta mediteraneana cu retete culinare: peste marinat, salata de varza alba sau rosie, se taie subtire, se sareaza usor, se stoarce zeama, apoi varza se asaza in salatiera, putin ulei de masline
Dieta mediteraneana creste longevitatea

Dieta mediteraneana creste longevitatea, studiile arata ca populatiile din tarile mediteraneene sint longevivi

38. Dieta mediteraneana traditionala reduce estrogenul endogen la femei sanatoase in postmenopauza

39. Acizii grasi esentiali polinesaturati Omega 3 din Ulei de Peste atenueaza cresterea cancerului mamar, prin activarea neutrala de mediere a sfingomielinaza

Pestele cu ulei de peste contine acizi grasi esentiali Omega 3 iar uleiul de masline contine acizi grasi mononesaturat Omega 9

Scurt si cuprinzator: acizii grasi esentiali sint substante nutritive sanatoase pentru organism ca: Acizii grasi polinesaturati Omega-3, Omega-6, Omega-9,

40. Barbatii obezi posed nivelul seric plasmatic ridicat de estron sulfat

41. Nivelul seric de estradiol la barbati cu infarct miocardic acut

Nivelul seric de estradiol la barbati cu infarct miocardic acut

42. Asociatia de hiperestrogenemia cu cardiopatia ischemica cronica la barbati

43. Evidenta de hiperestrogenemia un factor de risc in infarctul miocardic la barbati

Echilibru hormonal pentru barbati si femei: Diindolylmethane si Indole-3-Carbinol

Bibliografie -References: Echilibru hormonal

Informatii din bibliografia electronica la tema: Nutritie si sanatate

1. Bradlow HL, et al. 1991. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-74.
- Bradlow HL, Michnovicz J, Telang NT, Osborne MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Institute for Hormone Research, New York, NY 10016. Carcinogenesis. 1991 Sep;12(9):1571-4.
2. Colditz GA. Estrogen, estrogen plus progestin therapy, and risk of breast cancer. Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115. USA. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s.
3.Beresford SA, Weiss NS, Voigt LF, McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Departments of Epidemiology, University of Washington, Seattle 98195-7236, USA. Lancet. 1997 Feb 15;349(9050):458-61.
- Beral V, Bull D, Reeves G; Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2005 Apr 30-May 6;365(9470):1543-51.
4. Sturdee DW, Ulrich LG, Barlow DH, Wells M, Campbell MJ, Vessey MP, Nielsen B, Anderson MC, Bragg AJ. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Women's Health Unit, Birmingham Heartlands and Solihull Hospital NHS Trust, West Midlands, UK. BJOG. 2000 Nov;107(11):1392-400.
- Sturdee DW, Ulrich LG, Barlow DH, Wells M, Campbell MJ, Vessey MP, Nielsen B, Anderson MC, Bragg AJ. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Women's Health Unit, Birmingham Heartlands and Solihull Hospital NHS Trust, West Midlands, UK. BJOG 2001 Mar;108(3):335.
5. Moreno JG, Miller MC, Gross S, et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. 2005 Apr;65(4):713-8.
6. Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006 Nov 1;12(21):6403-9.
7. Beral V; Million Women Study Collaborators, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Million Women Study Coordinating Centre, Cancer Research UK Epidemiology Unit, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK. Lancet. 2007 May 19;369(9574):1703-10.
8. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Women's Health Initiative Branch, National Heart, Lung, and Blood Institute, Bethesda, Md 20892, USA. JAMA. 2007 Apr 4;297(13):1465-77.
9. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst. 1990; 50:947-950.
10. Ritter CL, Prigge WF, Reichert MA, Malejka-Giganti D, "Oxidations of 17 beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone." Can J Physiol Pharmacol. 2001 Jun;79(6):519-32.
11. C L Hayes, D C Spink, B C Spink, J Q Cao, N J Walker, and T R Sutter 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Department of Environmental Health Sciences, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MD 21205-2179, USA. Proc Natl Acad Sci U S A. 1996 September 3; 93(18): 9776–9781.
12. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Department of Biochemistry, Queen's University, Kingston, Ontario, Canada. Biochem Pharmacol. 1993 Mar 9;45(5):1129-36.
13. Chen I., et al., Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (AH) receptor agonists and antagonists in T47D human breast cancer cells. Biochemical Pharmacology 1996; 51:1069-1076. 14. Chen I, McDougal A, Wang F, Safe S; "Aryl hydrocarbon receptor-mediated antiiestrogenic and antitumorigenic activity of diindolylmethane." Carcinogenesis 1998 Sep;19(9):1631-9.
8. Riby JE, Chang GH, Firestone GL, Bjeldanes LF. "Ligand-independent activation of estrogen receptor function by 3,3'-diindolylmethane in human breast cancer cells." Biochem Pharmacol. 2000 Jul 15;60(2):167-77.
15. Michnovicz JJ, et al., Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst. 1997 May 21; 89(10):718-23.
16. Bradlow HL, et al., 2-hydroxyestrone: the 'good' estrogen. J Endocrinol. 1996 Sep; 150 Suppl:S259-65.
17. Zhu BT, et al., Is 2-Methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Research 1998 June 1; 58:2269-2277
18.Arneson, DW, Hurwitz, A, McMahon, LM, and Robaugh, D: "Presence of 3,3'-Diindolylmethane in human plasma after oral administration of Indole-3-carbinol." Proceedings of the American Association for Cancer Research, 1999 Mar; (40): 2833.
19. Rouzaud G, Young SA, Duncan AJ. Hydrolysis of glucosinolates to isothiocyanates after ingestion of raw or microwaved cabbage by human volunteers. Cancer Epidemiol Biomarkers Prev. 2004;13(1):125-131.
20. Leong H, Firestone GL, Bjeldanes LF, "Cytostatic effects of 3,3-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression." Carcinogenesis. 2001 Nov;22(11):1809-17.
21. Arneson DW, Hurwitz A, Crowell JA, Mayo MS, "Pharmacokinetics of 3-3'-Diindolylmethane following oral administration of Indole-3-carbinol to human subjects." American Association of Cancer Research, (41) 2001, #4658.
22. Janet Tou, Chibo Hong and Leonard F. Bjeldanes,"The Influence of 3'3-Diindolylmethane on Breast Tumor Growth, Invasion and Metastasis." Experimental Biology 2001, March 31-April 4, 2001, Orlando, Florida
23. Chibo Hong, Gary L. Firestone and Leonard F. Bjeldanes. "Induction of apoptosis in MCF-7 and MDA-MB-231 human breast cancer cells by 3,3'-diindolylmethane (DIM). " Experimental Biology 2001, March 31-April 4, 2001, Orlando, Florida.
24. Chibo Hong, Gary L. Firestone, and Leonard F. Bjeldanes, "3,3'-Diindolylmethane (DIM), a dietary indole, has multiple cell suppressive effects on MCF-7, human breast cancer cells." The American Society for Cell Biology, Fortieth Annual Meeting, December 2000, San Francisco, California.
25. Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive cancer. Am J Clin Nutr. 1987 Jan;45(1 Suppl):283-9.
26. Chang YC, Riby J, Chang GH, Peng BC, Firestone G, Bjeldanes LF. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Division of Nutritional Sciences and Toxicology, University of California, Berkeley 94720, USA. Biochem Pharmacol. 1999 Sep 1;58(5):825-34.
27. Munday R, Mhawech-Fauceglia P, Munday CM, Paonessa JD, Tang L, Munday JS, Lister C, Wilson P, Fahey JW, Davis W, Zhang Y. Inhibition of urinary bladder carcinogenesis by broccoli sprouts. AgResearch Limited, Ruakura Agricultural Research Center, Hamilton, New Zealand. Cancer Res. 2008 Mar 1;68(5):1593-600. Epub 2008 Feb 29.
28. Chen DZ, Qi M, Auborn KJ, Carter TH. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. North Shore-Long Island Jewish Research Institute, Manhasset, NY 11030, USA. J Nutr. 2001 Dec;131(12):3294-302.
29. Jang JJ, Cho KJ, Lee YS, Bae JH. Modifying responses of allyl sulfide, indole-3-carbinol and germanium in a rat multi-organ carcinogenesis model. Carcinogenesis 1991;4:691-695.
30. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells. Faculty of Food Engineering and Biotechnology, Technion- Israel Institute of Technology, 32000, Haifa, Israel. Food Chem Toxicol. 2003 Jun;41(6):745-52.
31. Frydoonfar HR, McGrath DR, Spigelman AD. The effect of indole-3-carbinol and sulforaphane on a prostate cancer cell line. Discipline of Surgical Science, Faculty of Health, The University of Newcastle, New South Wales, Australia. ANZ J Surg. 2003 Mar;73(3):154-6.
32. Zeligs MA, Sepkovic DW, Manrique CA, Macksalka M, Williams DE, Bradlow HL, "Absorption-enhanced 3,3-Diindolylmethane: human use in HPV-related, benign and pre-cancerous conditions." American Association of Cancer Research, (42) 2002, #103483.
33. Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Bergmannsheil, Bochum, Germany. J Clin Endocrinol Metab. 1993 Aug;77(2):375-81.
34. Dvorkin L, Song KY. Herbs for benign prostatic hyperplasia. Center for Integrative Therapies in Pharmaceutical Care, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115-5896, USA. Ann Pharmacother. 2002 Sep;36(9):1443-52.
35. Farnsworth WE, Roles of estrogen and SHBG in prostate physiology. The Prostate 1996; 28:17-23.
36. Nakhla AM, Romas NA, Rosner W. Estradiol activates the prostate androgen receptor and prostate-specific antigen secretion through the intermediacy of sex hormone-binding globulin. Department of Medicine, St. Luke's/Roosevelt Hospital Center, New York, New York 10019 and the College of Physicians and Surgeons, Columbia University, New York, New York 10019, USA. J Biol Chem. 1997 Mar 14;272(11):6838-41.
37. Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive cancer. Am J Clin Nutr. 1987 Jan;45(1 Suppl):283-9.
38. Carruba G, Granata OM, Pala V, et al. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutr Cancer. 2006;56(2):253-9.
39. Wu M, Harvey KA, Ruzmetov N, et al. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer. 2005 Nov 10;117(3):340-8.
40. Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N. Obese men have elevated plasma levels of estrone sulfate. Orentreich Foundation for the Advancement of Science Inc., Biomedical Research Station, Cold Spring-on-Hudson, NY 10516. Int J Obes. 1990 Jun;14(6):483-6.
41. Klaiber EL, Broverman DM, Haffajee CI, Hochman JS, Sacks GM, Dalen JE. Serum estrogen levels in men with acute myocardial infarction. Am J Med. 1982 Dec;73(6):872-81.
42. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983 May;74(5):863-9.
43. Philips GB, Evidence for hyperoestrogenaemia as a risk factor for myocardial infarction in men. Lancet 1976; 2(7975): 14-18.

Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate